Get the Stockscreener App
10.80
0.55%
-0.06
After Hours:
10.80
Dynavax Technologies Corp stock is traded at $10.80, with a volume of 1.07M.
It is down -0.55% in the last 24 hours and down -4.09% over the past month.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
See More
Previous Close:
$10.86
Open:
$10.89
24h Volume:
1.07M
Relative Volume:
0.66
Market Cap:
$1.27B
Revenue:
$260.81M
Net Income/Loss:
$20.48M
P/E Ratio:
83.08
EPS:
0.13
Net Cash Flow:
$22.67M
1W Performance:
-0.83%
1M Performance:
-4.09%
6M Performance:
+3.85%
1Y Performance:
-16.86%
1-Day Range:
$10.76
$10.91
1-Week Range:
$10.71
$11.18
52-Week Range:
$9.20
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Name
Dynavax Technologies Corp
Sector
Phone
(510) 848-5100
Address
2100 POWELL STREET, EMERYVILLE, CA
Compare DVAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
10.80 | 1.28B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | Goldman | Neutral → Sell |
| Feb-01-24 | Initiated | Goldman | Neutral |
| Sep-27-22 | Initiated | JMP Securities | Mkt Outperform |
| Jan-06-22 | Resumed | Goldman | Buy |
| Aug-06-21 | Initiated | Goldman | Buy |
| Aug-07-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-03-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-15-20 | Initiated | Evercore ISI | Outperform |
| Oct-18-19 | Initiated | H.C. Wainwright | Buy |
| Jul-11-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-27-19 | Reiterated | Cantor Fitzgerald | Overweight |
| May-10-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Feb-14-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-25-17 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-15-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-31-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-31-17 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Apr-28-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-27-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Initiated | RBC Capital Mkts | Outperform |
| Nov-25-13 | Upgrade | MLV & Co | Hold → Buy |
| Feb-25-13 | Downgrade | MLV & Co | Buy → Hold |
| Nov-16-12 | Reiterated | MLV & Co | Buy |
View All
Dynavax Technologies Corp Stock (DVAX) Latest News
Dynavax Technologies Corporation $DVAX Shares Acquired by American Century Companies Inc. - Defense World
Dynavax Technologies Through the Nasdaq Index Shows Global Health Role - Kalkine Media
State Board of Administration of Florida Retirement System Decreases Position in Dynavax Technologies Corporation $DVAX - MarketBeat
Capital Fund Management S.A. Takes $1.67 Million Position in Dynavax Technologies Corporation $DVAX - Defense World
Dynavax Technologies Corporatio (DVAX) Stock Forecasts - Yahoo Finance
Will Dynavax Technologies Corporation (DYF1) stock deliver compounding returnsJuly 2025 Recap & High Accuracy Buy Signal Tips - Newser
Assessing Dynavax After Recent Vaccine Progress and a 140% Five Year Share Price Surge - simplywall.st
Will Dynavax Technologies Corporation stock return to pre crisis levelsJuly 2025 WrapUp & Daily Entry Point Trade Alerts - Newser
Can Dynavax Technologies Corporation (DYF1) stock retain market dominanceInsider Selling & Precise Buy Zone Tips - Newser
Is Dynavax Technologies Corporation (DYF1) stock attractive for dividend growthJuly 2025 Institutional & Verified Short-Term Plans - Newser
How a Covid vaccine deal could fuel this South S.F. company's work against other viruses - The Business Journals
Evercore Healthcare Conference - marketscreener.com
Dynavax Technologies Corporation (0IDA.L) stock price, news, quote and history - Yahoo Finance UK
DVAX Crosses Below Key Moving Average Level - Nasdaq
Handelsbanken Fonder AB Sells 8,200 Shares of Dynavax Technologies Corporation $DVAX - Defense World
Geode Capital Management LLC Sells 377,048 Shares of Dynavax Technologies Corporation $DVAX - MarketBeat
Advantage Alpha Capital Partners LP Reduces Position in Dynavax Technologies Corporation $DVAX - Defense World
Entropy Technologies LP Has $190,000 Holdings in Dynavax Technologies Corporation $DVAX - MarketBeat
Dynavax Technologies Corporation (NASDAQ:DVAX) Receives $24.33 Average Price Target from Analysts - Defense World
First Week of July 2026 Options Trading For Dynavax Technologies (DVAX) - Nasdaq
Dynavax Technologies Corp (DYF1.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Dynavax Technologies Corporatio (DVAX) Stock forecasts - Yahoo Finance UK
Dynavax Technologies Corporation (0IDA.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bank of New York Mellon Corp Sells 199,158 Shares of Dynavax Technologies Corporation $DVAX - MarketBeat
Is Dynavax Technologies Corporation (DYF1) stock a defensive play amid uncertainty2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Dynavax (Nasdaq: DVAX) to Join Evercore Healthcare Conference Fireside Chat on Dec. 2 - Stock Titan
Why Dynavax Technologies Corporation (DYF1) stock remains top ratedRate Hike & Low Risk Entry Point Tips - newser.com
Can Dynavax Technologies Corporation stock deliver consistent earnings growthWeekly Risk Summary & Precise Trade Entry Recommendations - newser.com
Is Dynavax Technologies Corporation showing signs of accumulation2025 Price Targets & Long-Term Investment Growth Plans - newser.com
Why Dynavax Technologies Corporation (DYF1) stock fits value portfoliosTake Profit & Technical Pattern Based Buy Signals - newser.com
Campbell & CO Investment Adviser LLC Sells 24,624 Shares of Dynavax Technologies Corporation $DVAX - Defense World
Can Dynavax Technologies Corporation stock reach $100 price targetSell Signal & Smart Allocation Stock Tips - newser.com
How Dynavax Technologies Corporation stock responds to policy changesWeekly Market Report & Low Drawdown Momentum Ideas - newser.com
Vaxart, Inc. Enters Exclusive License Agreement with Dynavax for COVID-19 Oral Vaccine Candidate, Completes Phase 2b Enrollment and Reports Q3 2025 Financial Results | VXRT Stock News - Quiver Quantitative
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results - Yahoo Finance
What institutional flow reveals about Dynavax Technologies CorporationWeekly Profit Report & Low Drawdown Investment Ideas - newser.com
Is Dynavax Technologies Corporation (DYF1) stock protected from inflationJuly 2025 Setups & AI Enhanced Trading Signals - newser.com
What dividend safety score for Dynavax Technologies Corporation stockInflation Watch & Verified Technical Signals - newser.com
Dynavax Technologies Corp Stock (DVAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dynavax Technologies Corp Stock (DVAX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Maste | 10% Owner |
Aug 21 '25 |
Sale |
11.03 |
1,094,994 |
12,077,784 |
16,696,492 |
| Deep Track Biotechnology Maste | 10% Owner |
Aug 22 '25 |
Sale |
10.59 |
970,143 |
10,273,814 |
15,726,349 |
| Novack David F | President & COO |
Mar 24 '25 |
Option Exercise |
6.80 |
10,000 |
68,050 |
18,078 |
| Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
1.48%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):